The Computational Science of Drug Development

Episode 20 • November 15, 2022 • 01:10:51
The Computational Science of Drug Development
Big Compute
The Computational Science of Drug Development

Nov 15 2022 | 01:10:51

/

Show Notes

At the beginning of 2020, while a pandemic of epic proportions shut down most of the world, the life sciences industry was kicked into high gear, pushing to do what had never been done before – create a vaccine in less than four years.  Thankfully, modern day computational science lended a hand, making the previously impossible, possible.  In this episode, we speak to someone on the front lines of vaccine and drug development – Steve Mehrman of Johnson & Johnson, who harnesses computational power on a daily basis to elevate one of the most important aspects of our lives – human health.

Other Episodes

Episode 3

March 14, 2019 • 00:21:47
Episode Cover

Boom Supersonic – Pushing Boundaries in Aerospace Design

Gabriel Broner interviews Josh Krall, the CTO of Boom Supersonic. Boom is designing the next generation of supersonic airliners using HPC that is entirely...

Listen

Episode 0

March 28, 2019 • 00:47:37
Episode Cover

Accelerating HPC Workflows with AI

In this Big Compute Podcast episode, Gabriel Broner hosts Dave Turek, Vice President of HPC and Cognitive Systems at IBM, to discuss how AI...

Listen

Episode 0

November 20, 2019 • 00:38:10
Episode Cover

FedRAMP, GPUs and the future of Federal Agency Computing

Kevin Kelly hosts Christopher Chang,  Computational Scientist and Acting HPC User Program Lead at the National Renewable Energy Laboratory. They discuss the incredible capability...

Listen